U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Uterine Corpus Cancer

MedGen UID:
1756027
•Concept ID:
C5418244
•
Neoplastic Process

Definition

Uterine corpus cancer that is resistant to treatment. [from NCI]

Recent clinical studies

Etiology

Clinical implication of psoas muscle mass measurement for predicting death within 3 months in patients with incurable uterine cervical or corpus malignancy.
Kurosu H, Todo Y, Yamada R, Minowa K, Tsuruta T, Minobe S, Matsumiya H, Kato H, Mori Y
Jpn J Clin Oncol 2021 Apr 1;51(4):577-583. doi: 10.1093/jjco/hyaa248. PMID: 33395489
A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a Gynecologic Oncology Group study.
Asbury R, Blessing JA, Moore D
Am J Clin Oncol 1996 Aug;19(4):400-2. doi: 10.1097/00000421-199608000-00017. PMID: 8677914

Diagnosis

Clinical implication of psoas muscle mass measurement for predicting death within 3 months in patients with incurable uterine cervical or corpus malignancy.
Kurosu H, Todo Y, Yamada R, Minowa K, Tsuruta T, Minobe S, Matsumiya H, Kato H, Mori Y
Jpn J Clin Oncol 2021 Apr 1;51(4):577-583. doi: 10.1093/jjco/hyaa248. PMID: 33395489
Hodgkin's lymphoma of the uterus presenting as refractory pelvic inflammatory disease. A case report.
Raggio ML, Bostrom SG, Harden EA
J Reprod Med 1988 Oct;33(10):827-30. PMID: 3193414

Therapy

A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a Gynecologic Oncology Group study.
Asbury R, Blessing JA, Moore D
Am J Clin Oncol 1996 Aug;19(4):400-2. doi: 10.1097/00000421-199608000-00017. PMID: 8677914
Hodgkin's lymphoma of the uterus presenting as refractory pelvic inflammatory disease. A case report.
Raggio ML, Bostrom SG, Harden EA
J Reprod Med 1988 Oct;33(10):827-30. PMID: 3193414
Quantitation of uterine activity after vaginal administration of prostaglandins.
Henzl MR, Arvealo TN, Noriega L, Aznar R, Ortega E, Segre E
Adv Biosci 1973;9:767-72. PMID: 4805889

Prognosis

Clinical implication of psoas muscle mass measurement for predicting death within 3 months in patients with incurable uterine cervical or corpus malignancy.
Kurosu H, Todo Y, Yamada R, Minowa K, Tsuruta T, Minobe S, Matsumiya H, Kato H, Mori Y
Jpn J Clin Oncol 2021 Apr 1;51(4):577-583. doi: 10.1093/jjco/hyaa248. PMID: 33395489

Clinical prediction guides

Clinical implication of psoas muscle mass measurement for predicting death within 3 months in patients with incurable uterine cervical or corpus malignancy.
Kurosu H, Todo Y, Yamada R, Minowa K, Tsuruta T, Minobe S, Matsumiya H, Kato H, Mori Y
Jpn J Clin Oncol 2021 Apr 1;51(4):577-583. doi: 10.1093/jjco/hyaa248. PMID: 33395489

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...